Ravi Salgia, MD, PhD

Professor of Medicine, Pathology and Dermatology

Director, Chest Oncology and Thoracic Oncology Research Program

Vice Chair, Translational Research

Dr. Ravi Salgia is an expert in thoracic oncology. He has clinical expertise in thoracic oncology, and has developed a strong program in novel therapeutics targeting thoracic malignancies. He has been practicing medical oncology with special expertise in thoracic oncology for more than 15 years. Dr. Salgia also consults on national and international cases in thoracic malignancies.

He has defined several novel targets in oncology, and leads a strong clinical and research group. Dr. Salgia is developing potential biomarkers that would be useful for early diagnosis, linkage to prognosis, and therapeutic monitoring in these diseases.

His research includes studying targeted therapies that enhance the quality of life for patients with cancer. Specifically, he and his laboratory identified that targeting the receptor tyrosine kinases are important in lung cancer. Most recently, they identified unique mutations of the receptor tyrosine kinase c-Met. In addition, they have discovered important pathways in heat shock proteins. Dr. Salgia's clinical and research effort is to bring these advanced therapies for patient benefit. His work has been funded by the American Cancer Society, the National Cancer Institute, MARF, and the University of Chicago Research Cancer Center.

Dr. Salgia has published numerous articles in prestigious journals, and has contributed to books related to thoracic malignancies. He is also an associate editor for various journals, and consults in thoracic oncology for Best Doctors.

Practice Locations

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

The University of Chicago Medicine
5841 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice

1987

Board Certifications

Internal Medicine
Medical Oncology

Medical School

Loyola University, Chicago

Internship and Residency

Johns Hopkins Hospital, Baltimore

Fellowship

Dana-Farber Cancer Institute/Harvard Medical School

Memberships

American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
International Association for the Study of Lung Cancer

Languages Spoken

English
Hindi
Spanish

Email

rsalgia@medicine.bsd.uchicago.edu

Office Phone

(773) 702-6149

Office Fax

(773) 702-3002

Office Postal Address

Ravi Salgia, MD, PhD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 2115
Chicago, IL 60637

Clinical Interests

• Medical oncology
• Thoracic oncology
• Lung cancer
• Mesothelioma
• Carcinoid tumors
• Thymomas
• Esophageal cancer
• Mediastinal tumors

Request an appointment online
or call UCM Connect at
1-888-824-0200

Physicians, contact the
Referring Physician Access Line
at 1-877-DOM-2730

More About Dr. Salgia

Learn how Dr. Salgia collaborates with other experts to improve screening and prevention methods for patients at high risk for developing cancers of the upper aerodigestive tract.

View a video presentation of Dr. Salgia's lung cancer talk, "Lung Cancer Research: From Prevention to Cure."

A dedicated educator and mentor, Dr. Salgia delivered a lecture on translational research in lung cancer at a Grand Rounds event in Wisconsin. Watch his presentation.

When Tony Palumbo was faced with "incurable" non-small cell lung cancer, Dr. Salgia created a personalized treatment plan. Thanks to aggressive therapy and a positive approach, Palumbo is now cancer-free.

After Jim Chessare's successful surgery to remove a small mediastinal tumor, he was referred to Dr. Saglia to be evaluated for follow-up care.

Dr. Salgia is implanting human cancer mutations into tiny worms, in order to find out which genes make promising drug targets. Learn more about his work.

Selected Publications

View a partial list of Dr. Salgia's publications through the National Library of Medicine's PubMed online database.